Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors: Highlights from the "2013 ASCO gastrointestinal cancers symposium". San Francisco, CA, USA. january 24-26, 2013

Ryan Stevenson, Steven K. Libutti, Muhammad Wasif Saif

Research output: Contribution to journalArticle

3 Scopus citations


Neuroendocrine tumors (NET) are a diverse group of tumors that derive from epithelial cells with neuroendocrine differentiation. Gastroenteropancreatic NETs are a subset of NET that arise from the gastrointestinal tract. The natural history and prognosis varies widely between different gastroenteropancreatic NETs, highlighting the importance of identifying accurate prognostic and predictive biomarkers. At the 2013 ASCO Gastrointestinal Cancers Symposium, De Braud et al. (Abstract #186) and Bellister et al. (Abstract #163) present data on two new possible biomarkers.

Original languageEnglish (US)
Pages (from-to)155-157
Number of pages3
JournalJournal of the Pancreas
Issue number2
Publication statusPublished - Mar 1 2013



  • Biological markers
  • Gastro-enteropancreatic neuroendocrine tumors
  • Human
  • PHLPP2 protein
  • Succinate dehydrogenase

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this